In order to get more information on Luminal B/HER2-negative breast cancer, we have attempted to identify prognostic factors for early relapse, as well as to define an appropriate Ki-67 index cutoff in our center which might predict early relapse. This evidence concerns the gene ERBB2 and breast carcinoma.